StonvexLoading…
StonvexStonvexStonvexCore line items from OSW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $247.63M | $961.00M | $718.87M | $460.36M |
Operating Income | $22.87M | $81.64M | $65.27M | $38.96M |
Net Income | $21.33M | $71.62M | $59.56M | $35.21M |
EPS (Diluted) | $0.21 | $0.69 | $0.57 | $0.34 |
Total Assets | $709.88M | $707.10M | $732.60M | $731.82M |
Total Liabilities | $148.13M | $164.52M | $179.80M | $183.49M |
Cash & Equivalents | $16.08M | $16.31M | $29.56M | $35.03M |
Free Cash Flow OCF − CapEx | $4.75M | $68.45M | $53.54M | $25.98M |
Shares Outstanding | 102.31M | 103.67M | 104.10M | 104.34M |